GZERO Media logo
{{ subpage.title }}

Quick Take: Latest vaccine news may be a light at the end of the tunnel

Ian Bremmer's Quick Take:

Hey, everybody. Ian Bremmer here, happy Monday, Thanksgiving week. Things starting to look increasingly normal in terms of outlook, in terms of having all of these vaccines. I understand that the next few months in the United States are going to be incredibly challenging, but so much easier when you see that there's light at the end of the tunnel and you know where that's coming. Most recently, the AstraZeneca announcement, which for me, in some ways is a bigger deal globally, even than what we've seen from Moderna and Pfizer, because it doesn't require freezing, it's just refrigeration, which means that countries around the world that don't have the infrastructure to deal with this cold chain requirements of these vaccines will be able to use another set of vaccines with different technology. That's not just AstraZeneca, it will be Johnson and Johnson. It's the Russians. It's the Chinese.

Read Now Show less

GZERO Media Town Hall: Ending the COVID-19 Pandemic

GZERO Media, in partnership with the Bill and Melinda Gates Foundation and Eurasia Group, today hosted its second virtual town hall on the hunt for a COVID-19 vaccine and the challenges of its distribution.

The panel was moderated by New York Times science and health reporter Apoorva Mandavilli and featured Gates Foundation's Deputy Director of Vaccines & Human Immunobiology, Lynda Stuart; Eurasia Group's Rohitesh Dhawan, Managing Director of Energy, Climate & Resources; Gates Foundation CEO Mark Suzman; and Gayle E. Smith, the president & CEO of ONE Campaign and former Administrator of the U.S. Agency for International Development.

Watch the full video above.

Read Now Show less

Panel: How will the world recover from COVID-19?

On September 23, GZERO Media — in partnership with Microsoft and Eurasia Group — gathered experts to discuss global recovery from the coronavirus pandemic in a livestream panel. Our panel for the discussion Crisis Response & Recovery: Reimagining while Rebuilding, included:

  • Brad Smith, President, Microsoft
  • Ian Bremmer, President and Founder, Eurasia Group & GZERO Media
  • Jeh Johnson, Partner, Paul, Weiss, Rifkind, Wharton & Garrison, LLP and former Secretary of Homeland Security.
  • John Frank, Vice President, UN Affairs at Microsoft
  • Susan Glasser, staff writer and Washington columnist, The New Yorker (moderator)

Special appearances by UN Secretary-General António Guterres, European Central Bank chief Christine Lagarde, and comedian/host Trevor Noah.

Read Now Show less

Putin is still winning

At first glance, it's been a tumultuous few weeks for Russia's president Vladimir Putin.

There have been large anti-Kremlin protests in Russia's Far East. Putin critic Alexei Navalny has survived an assassination attempt that many now blame squarely on Russia's president. Turmoil in neighboring Belarus reminds many of the troubles Russia faced six years ago in Ukraine.

Look more closely, and Putin is sitting prettier than you'd think.

Read Now Show less

The US COVID response under Trump was not "merely mediocre"

An op-ed in the New York Times says that the US coronavirus response under President Trump was mediocre, but not catastrophic, when compared to the response of other countries. But the "peer country" examples selected by columnist Ross Douthat don't paint an accurate picture. Ian Bremmer and Eurasia Group analyst Scott Rosenstein take issue with Douthat's argument in this edition of The Red Pen (where we keep op-eds honest).

Today, we're taking our red pen to a recent piece from New York Times columnist Ross Douthat. The title is provocative, "How Many Lives Would a More Normal President Have Saved?" It sounds like Douthat is about to go big on the failure of President Trump's response to the pandemic. But no, that's just the headline. In reality, what he's saying is it isn't a catastrophe and may end up just being, meh, especially when you compare the US to peer nations. Not so fast, Ross. Let's break down the argument and get out the red pen.

Read Now Show less

Latest